Mail

UK markets close in 7 hours 8 minutes

FTSE 100
8,354.92
+0.87(+0.01%)
FTSE 250
20,484.52
-7.47(-0.04%)
AIM
780.88
+1.05(+0.13%)
GBP/EUR
1.1619
-0.0003(-0.03%)
GBP/USD
1.2475
-0.0022(-0.18%)
Bitcoin GBP
49,124.89
-760.18(-1.52%)

Bank of England expected to hold interest rates

Investors predict MPC will maintain interest at 5.25% when it meets on Thursday.

LSL Pharma Group Inc. (LSL.V)

TSXV - TSXV Real-time price. Currency in CAD

Add to watchlist

0.4500

0.0000

(0.00%)

At close: 03:58PM EDT

Currency in CAD

Valuation measures⁴

Market cap (intra-day)	48.60M
Enterprise value	58.88M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	7.03
Price/book (mrq)	4.98
Enterprise value/revenue	7.01
Enterprise value/EBITDA	-16.29

Trading information

Stock price history

Beta (5Y monthly)	N/A
52-week change ³	-13.46%
S&P500 52-week change ³	25.59%
52-week high ³	0.5700
52-week low ³	0.3500
50-day moving average ³	0.4069
200-day moving average ³	0.4437

Share statistics

Avg vol (3-month) ³	39.98k
Avg vol (10-day) ³	8.85k
Shares outstanding ⁵	108M
Implied shares outstanding ⁶	108M
Float ⁸	54.11M
% held by insiders ¹	2.62%
% held by institutions ¹	0.00%
Shares short (30 Apr 2024) ⁴	77
Short ratio (30 Apr 2024) ⁴	0.03
Short % of float (30 Apr 2024) ⁴	N/A
Short % of shares outstanding (30 Apr 2024) ⁴	0.00%
Shares short (prior month 15 Mar 2024) ⁴	124

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2022
Most-recent quarter (mrq)	30 Sept 2023

Profitability

Profit margin	-124.30%
Operating margin (ttm)	-13.38%

Management effectiveness

Return on assets (ttm)	-13.55%
Return on equity (ttm)	-119.74%

Income statement

Revenue (ttm)	8.86M
Revenue per share (ttm)	0.11
Quarterly revenue growth (yoy)	-4.90%
Gross profit (ttm)	N/A
EBITDA	-5.3M
Net income avi to common (ttm)	-11.01M
Diluted EPS (ttm)	-0.0500
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	N/A
Total cash per share (mrq)	N/A
Total debt (mrq)	13.88M
Total debt/equity (mrq)	142.38%
Current ratio (mrq)	0.42
Book value per share (mrq)	0.12

Cash flow statement

Operating cash flow (ttm)	-8.48M
Levered free cash flow (ttm)	-4.18M